(Q43047909)

12 November 2017

Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response (English)

1 reference

12 November 2017

1 reference

1 reference

Jane H Wang

1

1 reference

PubMed ID

12826368

12 November 2017

Thomas J Layden

series ordinal

2

1 reference

PubMed ID

12826368

12 November 2017

David D Eckels

series ordinal

3

1 reference

12 November 2017

1 July 2003

1 reference

12 November 2017

1 reference

12 November 2017

64

1 reference

12 November 2017

7

1 reference

12 November 2017

662-673

1 reference

Stealth, sabotage and exploitation

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

The great escape - AIDS viruses and immune control

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immunopathogenesis of HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

T cell responses and viral escape

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immunologic control of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immunology of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immune responses and immunity in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Interaction between the hepatitis C virus and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immunity to hepatitis C virus: stunned but not defeated

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Viral escape and the failure of cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Role of the specific T-cell response for clearance and control of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Hepatitis C virus: models of immunopathogenesis and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

1 reference

7 January 2021

Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

CD4+ T-cell-epitope escape mutant virus selected in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Th2 cell clonal anergy as a consequence of partial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2803%2900070-3

7 January 2021

10.1016/S0198-8859(03)00070-3

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

12826368